-
1
-
-
0031014450
-
Cancer statistics, 1997
-
Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47:5-27.
-
(1997)
CA Cancer J Clin
, vol.47
, pp. 5-27
-
-
Parker, S.L.1
Tong, T.2
Bolden, S.3
Wingo, P.A.4
-
2
-
-
0028301959
-
Fatty acid synthesis: A potential selective target for antineoplastic therapy
-
Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, et al. Fatty acid synthesis: A potential selective target for antineoplastic therapy. Proc Nat Acad Sci US 1994; 91:6379-6383.
-
(1994)
Proc Nat Acad Sci US
, vol.91
, pp. 6379-6383
-
-
Kuhajda, F.P.1
Jenner, K.2
Wood, F.D.3
Hennigar, R.A.4
Jacobs, L.B.5
Dick, J.D.6
-
3
-
-
0029346969
-
The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer
-
Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, Soerensen FB. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. J Pathol 1995; 176:343-352.
-
(1995)
J Pathol
, vol.176
, pp. 343-352
-
-
Jensen, V.1
Ladekarl, M.2
Holm-Nielsen, P.3
Melsen, F.4
Soerensen, F.B.5
-
4
-
-
0028875706
-
OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate
-
Epstein JI, Carmichael M, Partin AW. OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology 1995; 45: 81-86.
-
(1995)
Urology
, vol.45
, pp. 81-86
-
-
Epstein, J.I.1
Carmichael, M.2
Partin, A.W.3
-
7
-
-
0030063936
-
Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage 1 breast carcinoma patients
-
Alo' PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage 1 breast carcinoma patients. Cancer 1996; 77:474-482.
-
(1996)
Cancer
, vol.77
, pp. 474-482
-
-
Alo', P.L.1
Visca, P.2
Marci, A.3
Mangoni, A.4
Botti, C.5
Di Tondo, U.6
-
8
-
-
0026649789
-
Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator
-
Shurbaji MS, Kuhajda FP, Pasternack GR, Thurmond TS. Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator. Am J Clin Pathol 1992; 97:686-691.
-
(1992)
Am J Clin Pathol
, vol.97
, pp. 686-691
-
-
Shurbaji, M.S.1
Kuhajda, F.P.2
Pasternack, G.R.3
Thurmond, T.S.4
-
9
-
-
0024453198
-
Haptoglobin-related protein (hpr) epitopes in breast cancer as a predictor of recurrence of the disease
-
Kuhajda FP, Piantadosi S, Pasternack GR. Haptoglobin-related protein (hpr) epitopes in breast cancer as a predictor of recurrence of the disease. N Engl J Med 1989; 321:636-641.
-
(1989)
N Engl J Med
, vol.321
, pp. 636-641
-
-
Kuhajda, F.P.1
Piantadosi, S.2
Pasternack, G.R.3
-
10
-
-
0029829119
-
Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer
-
Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Human Pathol 1996; 27:917-921.
-
(1996)
Human Pathol
, vol.27
, pp. 917-921
-
-
Shurbaji, M.S.1
Kalbfleisch, J.H.2
Thurmond, T.S.3
-
11
-
-
0026325636
-
Expression of haptoglobin-related protein in primary and metastatic breast cancers: A longitudinal study of 48 fatal tumors
-
Shurbaji MS, Pasternack GR, Kuhajda FP. Expression of haptoglobin-related protein in primary and metastatic breast cancers: A longitudinal study of 48 fatal tumors. Am J Clin Pathol 1991; 96:238-242.
-
(1991)
Am J Clin Pathol
, vol.96
, pp. 238-242
-
-
Shurbaji, M.S.1
Pasternack, G.R.2
Kuhajda, F.P.3
-
12
-
-
0002426107
-
OA-519 immunostaining for fatty acid synthesis portends poor prognosis in ovarian cancer
-
Hardman W, Gansler T, Schaffel S, Hennigar R. OA-519 Immunostaining for fatty acid synthesis portends poor prognosis in ovarian cancer. [Abstract] Mod Pathol 1996; 9:90A.
-
(1996)
Mod Pathol
, vol.9
-
-
Hardman, W.1
Gansler, T.2
Schaffel, S.3
Hennigar, R.4
-
13
-
-
0003527023
-
-
New York: J.B. Lippincott
-
Beahrs OH, Henson DE, Hutter RVP, Myers MH, editors. American Joint Committee on Cancer: Manual for Staging of Cancer, 3rd ed. New York: J.B. Lippincott, 1988. p 27-32.
-
(1988)
American Joint Committee on Cancer: Manual for Staging of Cancer, 3rd Ed.
, pp. 27-32
-
-
Beahrs, O.H.1
Henson, D.E.2
Hutter, R.V.P.3
Myers, M.H.4
-
14
-
-
9544258287
-
CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus
-
Roye GD, Myers RB, Brown D, Poczatek R, Beenken SW, Grizzle WE. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer 1996; 69:254-258.
-
(1996)
Int J Cancer
, vol.69
, pp. 254-258
-
-
Roye, G.D.1
Myers, R.B.2
Brown, D.3
Poczatek, R.4
Beenken, S.W.5
Grizzle, W.E.6
-
15
-
-
0029971427
-
Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer
-
Pizer ES, Wood FD, Heine HS, Romantsev FE, Pasternack GR, Kuhajda FP. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res 1996; 56:1189-1193.
-
(1996)
Cancer Res
, vol.56
, pp. 1189-1193
-
-
Pizer, E.S.1
Wood, F.D.2
Heine, H.S.3
Romantsev, F.E.4
Pasternack, G.R.5
Kuhajda, F.P.6
-
16
-
-
0029949512
-
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells
-
Pizer ES, Jackisch C, Wood FD, Pasternack GR, Davidson NE, Kuhajda FP. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res 1996; 56:2745-2747.
-
(1996)
Cancer Res
, vol.56
, pp. 2745-2747
-
-
Pizer, E.S.1
Jackisch, C.2
Wood, F.D.3
Pasternack, G.R.4
Davidson, N.E.5
Kuhajda, F.P.6
|